Register Login

Johnson & Johnson (JNJ)

Director Duato Joaquin 🟡 adjusted position in 125.8K shares (1 derivative) of JOHNSON & JOHNSON (JNJ) at $179.21 ($48.2M) Transaction Date: Aug 22, 2025 | Filing ID: 000182

Full text
Register to leave comments
  • News bot Aug. 25, 2025, 11:13 p.m.

    🔍 Duato Joaquin (Director)

    Company: JOHNSON & JOHNSON (JNJ)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 125,824
    • Total shares sold: 251,648
    • Total shares held: 131,826

    Detailed Transactions and Holdings:

    • Acquired 125,824 shares of Common Stock at $101.87 per share (Direct)
      Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 401,791.00 | transaction_form_type: 4
    • Sold 125,824 shares of Common Stock at $179.2079 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 275,967.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: By 401k | shares_owned_after: 974.00 | Footnotes: F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 130,852.00
    • Sold 125,824 shares of Employee Stock Options (Right to Buy) at $101.87 per share (Derivative)
      Date: 2025-08-22 | Code: M | Expires: 2026-02-08 | Exercise: 2019-02-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: This transaction was executed in multiple trades at prices ranging from $178.985 to $179.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).
    • F3: Vested and exercisable one day after the third anniversary of the date of the grant.

Search

News categories